Norovirus nursing: contact precautions, bleach disinfection, and dehydration management

Norovirus is the leading cause of acute gastroenteritis worldwide. It is found in about 18% of acute gastroenteritis cases globally (Ahmed 2014), and the CDC estimates 685 million cases a year worldwide, including 200 million in children under 5. Lopman and colleagues (2016) put global deaths at over 200,000 a year, mostly in developing countries. In the United States, the CDC estimates norovirus causes 19–21 million illnesses, 2.27 million outpatient visits, 465,000 emergency department visits, 109,000 hospitalizations, and 900 deaths a year, the deaths mostly among adults 65 and older. For nurses, norovirus is a serious clinical problem – in vulnerable populations (elderly nursing home residents, immunocompromised patients, infants) it can cause severe dehydration, electrolyte imbalances, and death. In healthcare settings, norovirus outbreaks can force unit closures, cohorting of patients, and suspension of admissions.

This reference covers pathophysiology, clinical presentation, nursing assessment, fluid and electrolyte management, infection control priorities (including the critical difference between norovirus and bacteria like C. diff when it comes to hand hygiene and disinfectants), patient education, and six NCLEX-style practice questions.

Fast-scan summary

Pathophysiology

Viral structure and why it matters for infection control

Norovirus is a non-enveloped RNA virus. This structural feature is clinically important: without a lipid envelope, norovirus is much less susceptible to alcohol-based hand rubs, which act most readily on enveloped viruses. Laboratory work summarized in the 2011 HICPAC guideline found that even 70–90% ethanol could not reduce the surrogate feline calicivirus by 99.9% after 10 minutes. This places norovirus alongside C. difficile (though for different reasons – C. diff resists alcohol because of its spore form) as an organism where soap and water is the preferred hand hygiene method after patient contact.

Norovirus also has an extraordinarily low infectious dose. Human challenge modelling (Teunis et al. 2008) estimated the probability of infection from a single Norwalk virus particle at close to 0.5 – higher than for any other virus studied at the time. CDC guidance gives an infectious dose as low as 18 viral particles, and CDC teaching materials quote a range of 18–1,000, so “18 particles” is the low end of a range rather than a fixed threshold. In experimentally infected volunteers, peak shedding reached a median of about 95 billion genomic copies per gram of stool, and virus was detectable by PCR for a median of 28 days (range 13–56) (Atmar 2008). The HICPAC review found that dried norovirus can persist at room temperature for up to 21–28 days. This combination – low infectious dose, high shedding volume, environmental stability, and poor susceptibility to alcohol – explains why norovirus spreads with exceptional efficiency in congregate settings.

Mechanism of disease

After ingestion, norovirus infects the epithelial cells lining the small intestine. The virus does not invade the mucosa or cause ulceration; instead, it disrupts the structure and function of intestinal villi. Infection causes:

• Villous blunting – reduction in absorptive surface area, impairing nutrient and fluid absorption
• Impaired sodium-glucose cotransport – reducing the efficiency of the primary intestinal water absorption mechanism
• Accelerated gut transit – liquid content passes through the colon before adequate water absorption occurs, producing watery diarrhea
• Delayed gastric emptying – contributes to nausea and vomiting

The combination of impaired absorption and increased secretion produces net fluid loss into the bowel lumen. In healthy adults, compensatory mechanisms limit the severity; in infants, elderly patients, and those with underlying illness, fluid and electrolyte losses can rapidly become clinically significant.

Symptoms typically resolve within 1–3 days in otherwise healthy people, although illness lasting 4–6 days is seen in young children, older adults, and hospitalized patients (Hall 2011, MMWR). Immunity after infection is incomplete and largely genotype-specific, with little cross-protection between strains. CDC states that it is not known exactly how long protection lasts, which is why people can have norovirus many times in their lives. There is no licensed norovirus vaccine. Several candidates are in development (Carlson 2024), and the largest, Moderna’s mRNA-1403 phase 3 trial in adults (NCT06592794), had not reported efficacy as of October 2026.

Why fluid and electrolyte loss is the central nursing concern

The predominant pathological consequence of norovirus infection is isotonic dehydration with concurrent losses of sodium, potassium, chloride, and bicarbonate through diarrhea and emesis. In elderly patients, the physiological reserve for fluid shifts is reduced, baseline kidney function may be impaired, and thirst sensation is blunted – all of which accelerate the transition from mild to moderate-to-severe dehydration. Review the site’s electrolyte imbalances reference for a full breakdown of the expected lab abnormalities in dehydration states.

Clinical presentation

Signs and symptoms

Dehydration severity classification

The percentage bands below come from CDC guidance for children with acute gastroenteritis (King 2003), which groups mild and moderate dehydration together at a 3–9% deficit. Weight-based bands are less validated in adults, where serial vital signs, urine output, and labs carry more weight.

Assessment and diagnosis

Nursing assessment priorities

The first nursing priority is fluid status assessment. In norovirus, the question is not whether the patient has gastroenteritis – clinically obvious – but whether they are progressing to clinically significant dehydration that requires escalation. A thorough assessment includes:

Vital signs – Tachycardia is often an early objective sign of dehydration. Orthostatic hypotension is a fall in systolic BP of ≥20 mmHg or diastolic BP of ≥10 mmHg on standing. In a JAMA rational clinical examination review (McGee 1999), a postural pulse rise of ≥30 beats/min or severe postural dizziness was the most useful bedside sign of hypovolemia, although it was often absent with moderate losses. Hypotension at rest signals hemodynamic compromise. Review the vital signs by age reference for age-specific baseline ranges when assessing pediatric or geriatric patients.

Intake and output – Accurate I&O is essential. Urine output less than 0.5 mL/kg/hour indicates inadequate renal perfusion. Weigh the patient daily (same time, same scale) – each kilogram of weight lost acutely represents approximately 1 liter of fluid deficit.

Mucous membranes and skin turgor – Dry lips and oral mucosa, a dry axilla, and sunken eyes are hydration markers; moist mucous membranes and a tongue without furrows argue against hypovolemia (McGee 1999). Skin turgor has no proven diagnostic value in adults, and reduced skin elasticity makes it especially unreliable in older patients – rely more heavily on vital signs, urine output, and labs.

Mental status – In elderly patients, confusion or increased lethargy can be the presenting sign of dehydration rather than a late finding. Any acute change in mental status should prompt urgent reassessment of fluid balance.

Stool characteristics – Document frequency, volume (estimate), consistency, color, and presence of blood or mucus. Bloody diarrhea is NOT typical of norovirus and should raise suspicion for bacterial gastroenteritis (Salmonella, Shigella, Campylobacter, E. coli O157:H7), ischemic colitis, or inflammatory bowel disease flare – escalate to the provider.

Abdominal assessment – Diffuse mild tenderness is expected. Rebound tenderness, involuntary guarding, rigidity, or absent bowel sounds should prompt immediate provider notification to rule out surgical causes (appendicitis, bowel obstruction, peritonitis). See the site’s peritonitis nursing reference for escalation criteria.

Diagnostic workup

Norovirus gastroenteritis is typically a clinical diagnosis based on history and presentation. In outbreaks without lab results, HICPAC recommends Kaplan’s criteria: vomiting in more than half of symptomatic cases, a mean (or median) incubation period of 24–48 hours, a mean (or median) illness duration of 12–60 hours, and no bacterial pathogen in stool culture. In 362 confirmed gastroenteritis outbreaks reported to CDC, the criteria were 68% sensitive and 99% specific, so a cluster that meets them is very likely norovirus, while one that does not may still be. HICPAC notes they have not been tested specifically in healthcare outbreaks.

Laboratory testing – Not routinely indicated for mild disease in healthy adults. Ordered when:

• Severe dehydration, signs of systemic illness, or immunocompromised status
• Prolonged illness (>72 hours) or failure to improve
• Bloody diarrhea (to rule out bacterial pathogens)
• Outbreak investigation (stool PCR or RT-PCR for norovirus confirmation)

Key lab findings in dehydration

See the nursing lab values cheat sheet for normal reference ranges and full interpretation guidance.

Nursing interventions

Prioritized interventions with rationale

Fluid and electrolyte management

Oral rehydration therapy

Oral rehydration therapy (ORT) is the preferred first-line treatment for mild-to-moderate dehydration from viral gastroenteritis in patients who are alert and can swallow safely. ORT exploits the sodium-glucose cotransport mechanism in small intestinal enterocytes, which remains partially functional even when general absorptive capacity is impaired by norovirus infection. Glucose in the ORS facilitates sodium absorption, which draws water along osmotically.

The WHO/UNICEF reduced-osmolarity ORS formulation contains: sodium 75 mEq/L, chloride 65 mEq/L, glucose (anhydrous) 75 mmol/L, potassium 20 mEq/L, citrate 10 mEq/L – a total of 245 mOsm/L. Common commercial solutions such as Pedialyte contain less sodium (about 45 mEq/L) and are widely used for mild-to-moderate dehydration in high-income settings.

ORT nursing guidance:

• If the patient is vomiting, give small volumes (about 5 mL every 5 minutes by spoon or syringe), then increase gradually as tolerated (King 2003)
• Avoid plain water alone (lacks electrolytes; risks hyponatremia if used exclusively in prolonged illness)
• Avoid sports drinks (Gatorade, Powerade) as primary rehydration – high glucose, low sodium; high glucose content can worsen osmotic diarrhea
• Avoid juice, gelatin desserts, and other highly sugared liquids, which CDC pediatric guidance lists as inappropriate for rehydration
• CDC pediatric guidance replaces a mild-to-moderate deficit with 50–100 mL/kg of ORS over 2–4 hours, then replaces ongoing losses with about 10 mL/kg per watery stool and 2 mL/kg per episode of vomiting (King 2003)

IV fluid management

IDSA recommends IV fluids for severe dehydration, shock, altered mental status, failure of ORS therapy, or ileus.

Fluid selection:

• Isotonic crystalloid (Lactated Ringer’s or 0.9% Normal Saline) for initial resuscitation
• LR is slightly more physiologically balanced and may reduce hyperchloremic metabolic acidosis compared to large volumes of NS
• If maintenance IV fluids are needed in children aged 28 days to 18 years, the 2018 AAP guideline recommends isotonic solutions with appropriate potassium chloride and dextrose, because hypotonic fluids raise the risk of hospital-acquired hyponatremia (Feld 2018)

Electrolyte replacement:

• Potassium: replace per protocol and facility limits for peripheral infusion; ensure adequate urine output before administering IV potassium
• Bicarbonate: rarely needed, since acidosis from diarrhea usually corrects with fluid replacement; give only per provider order
• Monitor BMP every 4–6 hours during active fluid resuscitation; reassess fluid responsiveness by tracking heart rate, blood pressure, urine output, and mental status trends

Refer to the electrolyte imbalances nursing reference for specific electrolyte replacement protocols and monitoring parameters.

Infection control

Why norovirus demands exceptional vigilance

Norovirus is among the most contagious infectious agents encountered in healthcare settings. The combination of extremely low infectious dose, massive viral shedding, prolonged environmental survival, poor susceptibility to alcohol, and aerosol generation during vomiting creates conditions for rapid, difficult-to-contain outbreaks. Healthcare settings – particularly long-term care facilities, hospitals, cruise ships, schools, and military facilities – are high-risk environments.

Precaution levels

How long norovirus precautions last

The 2011 HICPAC guideline (MacCannell et al.) sets the duration of isolation and staff exclusion:

• Patients: keep contact precautions for a minimum of 48 hours after symptoms resolve (Category IB). The CDC isolation Appendix A (updated September 2026) lists the same 48-hour minimum, or longer to control an institutional outbreak.
• Complex medical patients (cardiovascular, autoimmune, immunosuppressive, or renal disorders): consider a longer period, because they can have protracted shedding and relapse (Category II).
• Infants and young children under 2: consider extending precautions, and there is evidence for continuing contact precautions for up to 5 days after symptoms resolve (Category II).
• Ill healthcare personnel: exclude from work for a minimum of 48 hours after symptoms resolve (Category IB); CDC’s 2011 MMWR outbreak guidance gives 48–72 hours. Food handlers follow the same 48-hour minimum or longer local rules.

Symptoms ending does not mean shedding has stopped. Virus is detectable in stool for an average of about 4 weeks after infection (Hall 2011, MMWR), although whether that late-shed virus is infectious is unknown. This is why hand hygiene stays important after a patient or colleague comes off precautions.

Hand hygiene – the most critical intervention

Soap and water is the recommended method after caring for or having contact with a patient with suspected or confirmed norovirus (HICPAC 2011, Category IB during outbreaks). CDC states that hand sanitizer “does not work well against norovirus” and is no substitute for handwashing. HICPAC does allow FDA-compliant alcohol-based hand rub (ABHR) for other moments, such as before entering the room, and suggests that ethanol-based products (60–95%) be preferred during outbreaks; it lists the efficacy of ABHR against human norovirus as an unresolved research question. For NCLEX purposes, soap and water after norovirus patient contact is the answer. This parallels the soap-and-water preference for C. diff, although C. diff resists alcohol because of its spores rather than a missing envelope.

Proper soap-and-water technique: wet hands, apply soap, lather for at least 20 seconds covering all surfaces, rinse under running water, dry with disposable towel, use towel to turn off faucet.

Environmental decontamination

Many general-purpose disinfectants are not registered for norovirus, and the laboratory evidence for some quaternary ammonium (quat) products is mixed. HICPAC recommends EPA-registered products with label claims against norovirus, used at the manufacturer’s dilution and contact time. In practice that means one of two options:

• Chlorine bleach solution at 1,000–5,000 ppm on hard, nonporous surfaces (CDC)
  • CDC mixing guide: 5–25 tablespoons of household bleach (5%–8%) per gallon of water; 5 tablespoons per gallon of 5.25% bleach gives about 1,000 ppm, and 25 tablespoons about 5,000 ppm
  • Use the higher end of the range for fecally soiled surfaces and spills
  • Leave the bleach on the surface for at least 5 minutes (CDC)
• An EPA List G product (EPA’s registered antimicrobial products effective against norovirus). List G includes products based on several active ingredients, including hypochlorite, hydrogen peroxide, and some quats. Confirm that the label carries norovirus directions and keep the surface wet for the listed contact time.

Other practical points:

• Clean before you disinfect: remove visible soil first. In one study cited by HICPAC, detergent alone or disinfectant alone failed to remove norovirus from a surface, while cleaning followed by a 5,000 ppm hypochlorite product succeeded.
• Vomit spills: wear gloves, gown, mask, and eye protection; absorb with disposable towels and discard in a plastic bag; then disinfect the area and surrounding surfaces
• Cleaning frequency during outbreaks: HICPAC suggests unit-level cleaning twice daily and frequently touched surfaces (commodes, toilets, faucets, bed rails, telephones, door handles, computer equipment) three times daily, working from cleaner areas to dirtier ones
• Shared equipment: keep equipment such as stethoscopes and blood pressure cuffs dedicated to the patient where possible. Anything shared must be cleaned, then disinfected with an EPA-registered product before it is used on another patient, at the label’s contact time (HICPAC norovirus rec 27, Category IC; 2007 isolation guideline V.B.5)
• Linens: handle without agitating them to avoid dispersing virus, and bag them in the room. In hospitals, standard laundry processing is adequate, and HICPAC says double bagging or special laundering is not indicated. At home, CDC advises the longest available hot-water cycle and machine drying on the highest heat setting.

Outbreak management in healthcare settings

Norovirus outbreaks in healthcare facilities require immediate, coordinated infection control response. Outbreak case definitions are set by facilities and local health departments rather than a single national number, so any cluster of acute gastroenteritis on a unit should be reported straight away. HICPAC recommends starting active case-finding as soon as a cluster is detected, using a line list of exposed and symptomatic patients and staff. A norovirus outbreak is laboratory-confirmed when stool or vomitus from two or more ill people tests positive (Hall 2011, MMWR).

Nursing responsibilities in outbreak management:

1. Report immediately to charge nurse and infection control/epidemiology team – do not wait for laboratory confirmation; send stool specimens early, ideally within 2–3 days of symptom onset
2. Cohort patients – separate symptomatic patients from asymptomatic; minimize patient movement within and between units, and suspend group activities such as communal dining. HICPAC suggests that symptomatic and recovering patients leave the patient-care area only for essential care or treatment (rec 4a). When transport is necessary, remove and discard contaminated PPE and perform hand hygiene before leaving the room, then put on clean PPE at the destination (2007 isolation guideline V.B.4)
3. Limit admissions and transfers – HICPAC suggests considering closure of the affected unit to new admissions or transfers; the threshold and the reopening point depend on infection prevention’s risk assessment
4. Exclude ill staff from work for at least 48 hours after their symptoms resolve (HICPAC); staff who have recently recovered may be best placed to care for symptomatic patients until the outbreak ends
5. Enhance environmental cleaning – increase cleaning frequency with bleach or an EPA List G product, as described above
6. Food service controls – exclude ill food handlers until at least 48 hours after symptoms resolve, and remove shared or communal food from clinical areas for the duration of the outbreak
7. Visitor restrictions – restrict non-essential visitors from affected areas; screen and exclude visitors with symptoms, and make sure those who do visit follow hand hygiene and contact precautions

Patient and family education

Effective patient education for norovirus focuses on four areas: preventing spread to household contacts, managing symptoms at home, knowing when to seek further medical care, and safe return to work or school.

Hand hygiene – Teach that washing with soap and water is the method to rely on after using the bathroom or changing diapers, and before preparing food or eating. Hand sanitizer can be used in addition but does not work well against norovirus and does not replace handwashing (CDC). The patient should wash hands for at least 20 seconds. Because virus can still be shed for 2 weeks or more after recovery, household members should keep up careful handwashing well beyond the illness itself.

Cleaning at home – Clean up vomit or diarrhea right away while wearing gloves, then disinfect the area with a bleach solution of 5–25 tablespoons of household bleach per gallon of water, left on for at least 5 minutes, or with a product on EPA List G. Wash soiled laundry on the longest hot-water cycle and machine dry on high heat.

Fluid replacement at home – Instruct patient to sip oral rehydration solution frequently. If vomiting, start with very small amounts (1 teaspoon every few minutes) and increase gradually. Popsicles and ice chips count toward fluid intake. Avoid alcohol and caffeine. Children and elderly patients are at highest risk of rapid dehydration – monitor closely.

Eating – Return to a normal, age-appropriate diet as soon as the patient can manage it, during or right after rehydration. A strict BRAT (bananas, rice, applesauce, toast) diet is unnecessarily restrictive, and most people do not need to avoid dairy (CDC; IDSA). Infants should keep breastfeeding throughout. Avoid juice, soda, and other very sugary drinks while diarrhea continues.

When to seek emergency care:

• Signs of severe dehydration: no urination for 8+ hours (adults) / 6+ hours (children), sunken eyes, rapid heartbeat, dizziness on standing, confusion or extreme weakness
• Bloody diarrhea (not normal for norovirus)
• High fever (>39°C / 102.2°F)
• Symptoms not improving after 3 days
• Infants: fewer than 6 wet diapers/day, no tears when crying, sunken fontanelle

Return to work/school – Stay home until at least 48 hours after symptoms resolve. This is especially important for food handlers, healthcare workers, and people in childcare settings. Viral shedding can continue for 2 weeks or longer after clinical recovery, so strict hygiene should be maintained throughout this period.

NCLEX-style practice questions

Summary

Norovirus is a highly contagious, non-enveloped RNA virus that causes self-limiting acute gastroenteritis in healthy adults but can produce life-threatening dehydration in elderly patients, infants, and immunocompromised individuals. The central nursing priorities are: early and accurate dehydration assessment, prompt initiation of oral or IV rehydration therapy, and aggressive infection control to prevent spread. Two points differentiate norovirus infection control from routine practice. Soap and water is the recommended hand hygiene after patient contact, because alcohol-based hand rub works poorly against this non-enveloped virus. Surfaces need chlorine bleach at 1,000–5,000 ppm left on for at least 5 minutes, or an EPA List G product with a norovirus label claim used at its stated contact time. In healthcare settings, norovirus demands immediate outbreak response – cohorting, unit restrictions, staff exclusion, and enhanced cleaning – to protect vulnerable patients from a pathogen that spreads with exceptional efficiency.

References

1. Lopman BA, Reacher MH, Vipond IB, Bhatt S, Brown DW, Caul EO. Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002–2003. Emerg Infect Dis. 2004;10(10):1827–1834. doi:10.3201/eid1010.030941
2. Hall AJ, Rosenthal M, Gregoricus N, et al. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004–2005. Emerg Infect Dis. 2011;17(8):1381–1388. doi:10.3201/eid1708.101533
3. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006;35(2):275–290. doi:10.1016/j.gtc.2006.03.001
4. Teunis PFM, Moe CL, Liu P, Miller SE, Lindesmith L, et al. Norwalk virus: how infectious is it? J Med Virol. 2008;80(8):1468–1476. doi:10.1002/jmv.21237
5. Centers for Disease Control and Prevention. About norovirus. Updated April 24, 2024. Available at: https://www.cdc.gov/norovirus/about/index.html
6. World Health Organization; UNICEF. Oral Rehydration Salts: Production of the New ORS. Geneva: WHO; 2006.
7. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65(12):e45–e80. doi:10.1093/cid/cix669
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–S164. doi:10.1016/j.ajic.2007.10.007
9. Otter JA, Yezli S, Salkeld JA, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl):S6–S11. doi:10.1016/j.ajic.2012.12.004
10. Lopman B, Vennema H, Kohli E, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet. 2004;363(9410):682–688. doi:10.1016/S0140-6736(04)15641-9
11. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med. 2009;361(18):1776–1785. doi:10.1056/NEJMra0804575
12. Hall AJ, Lopman BA, Payne DC, Patel MM, Gastañaduy PA, et al. Norovirus disease in the United States. Emerg Infect Dis. 2013;19(8):1198–1205. doi:10.3201/eid1908.130465
13. Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):725–730. doi:10.1016/S1473-3099(14)70767-4
14. Carlson KB, Dilley A, O’Grady T, Johnson JA, Lopman B, et al. A narrative review of norovirus epidemiology, biology, and challenges to vaccine development. NPJ Vaccines. 2024;9(1):94. doi:10.1038/s41541-024-00884-2
15. Hall AJ, Vinjé J, Lopman B, et al; Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep. 2011;60(RR-3):1–18.
16. MacCannell T, Umscheid CA, Agarwal RK, Lee I, Kuntz G, Stevenson KB; Healthcare Infection Control Practices Advisory Committee. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(10):939–969. doi:10.1086/662025
17. Centers for Disease Control and Prevention. Preventing norovirus. Updated January 13, 2025. Available at: https://www.cdc.gov/norovirus/prevention/index.html
18. Centers for Disease Control and Prevention. Norovirus facts and stats. Updated May 8, 2024. Available at: https://www.cdc.gov/norovirus/data-research/index.html
19. US Environmental Protection Agency. List G: EPA’s registered antimicrobial products effective against norovirus. Updated June 3, 2026. Available at: https://www.epa.gov/pesticide-registration/list-g-epas-registered-antimicrobial-products-effective-against-norovirus
20. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008;14(10):1553–1557. doi:10.3201/eid1410.080117
21. Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med. 2016;13(4):e1001999. doi:10.1371/journal.pmed.1001999
22. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1–16.
23. McGee S, Abernethy WB 3rd, Simel DL. Is this patient hypovolemic? JAMA. 1999;281(11):1022–1029. doi:10.1001/jama.281.11.1022
24. Feld LG, Neuspiel DR, Foster BA, Leu MG, Garber MD, et al. Clinical practice guideline: maintenance intravenous fluids in children. Pediatrics. 2018;142(6):e20183083. doi:10.1542/peds.2018-3083
25. Centers for Disease Control and Prevention. Appendix A: type and duration of precautions recommended for selected infections and conditions (Siegel JD et al., 2007 isolation guideline). Updated September 11, 2026. Available at: https://www.cdc.gov/infection-control/hcp/isolation-precautions/appendix-a-type-duration.html